FSM Department of health and Social Affairs SOR Project
Project Abstract:
Out of the 102,843 people in the FSM, 47.3% reside in Chuuk, 35.2% in Pohnpei, 11.1% in Yap and 6.4% in Kosrae. Most of the people are known as "Micronesian" the known ethnicities are called Chuukese, Pohnpeian, Yapese and Kosraean. 70% of the entire population lives in the administrative centers. 70% of the total population lives in administrative (urban) while 30% live in rural areas or known as outer islands. Though each has its own mother language, with various dialects, most people understand and speak English.
Our current progress in our fight against Opioid began with 11,104 participants in prevention and awareness activities for 1,304 total hours from Year 2018-2021 and 12 receiving treatment and recovery support services as our assessment reveals that most of the population are not aware of opioid. Another gap per the assessment is the inventory accountability of the opioid. Most practitioners indicate high need for control of the opioid drugs. Although there were more gaps identified in the assessment, the two were the highest peak outcome in the assessment.
Based on annual data at the Behavioral Health and Wellness Program, there are currently 605 clients or patients served during the year 2019 to 2022. Some of these clients are at greater risk for OUD. This project will further conduct the chart review of this registry to better understanding the extend or burden of the situation.
The goal of the project is to establish and enhance prevention, treatment and recovery program for individuals with OUD as means to respond and to address all the risk factors for OUD and its pathway drugs.
FSM will drive to satisfy the following objectives to work toward its goal. The objectives are as follows: build capacity and infrastructure for data driven opioid abuse prevention, treatment and recovery at each of the FSM States: Chuuk, Pohnpei, Yap and Kosrae; increasing access to FDA-approved medications for the treatment of opioid use disorder; enhance continuum of prevention, harm reduction, treatment and recovery support services for opioid use disorder and other concurrent substance use disorders; enhance continuum of care for stimulant misuse and use disorders, including cocaine and methamphetamine; and reduce unmet treatment needs and opioid-related overdose deaths.